grant

Resolvin E1 is a novel anti-inflammatory and anti-fibrotic lipid mediator for the treatment of chronic kidney disease. [ 2010 - 2012 ]

Also known as: A natural anti-inflammatory compound for the treatment of chronic kidney disease.

Research Grant

[Cite as https://purl.org/au-research/grants/nhmrc/606400]

Researchers: A/Pr Jinhua Li (Principal investigator) ,  A/Pr David Nikolic-Paterson

Brief description This project will ascertain whether a naturally occurring compound, Resolvin E1 with potent anti-inflammatory properties, can effectively halt the progression of experimental kidney disease. We will also test whether Resolvin E1 can exert other potential benefits in suppressing progressive fibrosis of the kidney. The outcome of this study will allow us to evaluate the therapeutical potential of Resolvin E1 for the treatment of acute and chronic kidney diseases.

Funding Amount $AUD 519,246.28

Funding Scheme NHMRC Project Grants

Notes Standard Project Grant

Click to explore relationships graph
Identifiers
Viewed: [[ro.stat.viewed]]
ACN 633 798 857